Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Polycystic Ovary Syndrome × thymoquinone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Metformin 5 empagliflozin 2 Tablets 2 Letrozole 2 Clomiphene 2 thymoquinone 1 semaglutide 1 penclomedine 1 Vaginal Creams, Foams, and Jellies 1 Sitagliptin Phosphate 1 Ovidrel 1 Inositol 1 Folic Acid 1 Exenatide 1 Curcumin 1 Crinone 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04852510 2021-04-21

Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin

Saudi German Hospital - Madinah

Phase 2/3 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡